Search - tctmd.com

Displaying 381 - 400 of 1004

Sort: Relevancy | Date

News Daily News

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Shelley Wood

July 20, 2021

News Daily News

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

Caitlin E. Cox

July 14, 2021

News Daily News

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Yael L. Maxwell

July 09, 2021

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Caitlin E. Cox

July 06, 2021

News Daily News

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Todd Neale

July 06, 2021

News Daily News

Complete Revascularization Best for Most ACS Patients With MVD

Michael O'Riordan

June 25, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Daily News

Final SPRINT Results Endorse Intensive BP Control

Todd Neale

May 25, 2021

News Conference News ACC 2021

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Michael O'Riordan

May 25, 2021

News Industry News

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

May 25, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News ACC 2021

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Shelley Wood

May 16, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

News Daily News

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Michael O'Riordan

May 11, 2021

News Conference News ACC 2021

Prediabetes Linked to Higher MACE Risk

Todd Neale

May 10, 2021

News Daily News

FDA Approves Dapagliflozin for CKD Patients

Michael O'Riordan

May 03, 2021

News Conference News SCAI 2021

Cardiogenic Shock: Protocols, Clear Definitions Advance the Field

Caitlin E. Cox

April 30, 2021

News Daily News

Pneumonia in HF Patients Is Common, Lethal, and Preventable

L.A. McKeown

April 19, 2021

News Daily News

TAVI Beneficial Even in Eldest Patients, Registry Reaffirms

Caitlin E. Cox

April 19, 2021

Advertisement

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

Hospital Stays for Meth-Related HF Skyrocket, as Do Costs

FDA Approves Finerenone for Adults With CKD and Type 2 Diabetes

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results

Complete Revascularization Best for Most ACS Patients With MVD

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Final SPRINT Results Endorse Intensive BP Control

Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Dapagliflozin No Help, but No Harm, in Hospitalized COVID-19 Patients

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Finerenone Cuts CV Events in CKD Patients With Diabetes: FIGARO-DKD

Prediabetes Linked to Higher MACE Risk

FDA Approves Dapagliflozin for CKD Patients

Cardiogenic Shock: Protocols, Clear Definitions Advance the Field

Pneumonia in HF Patients Is Common, Lethal, and Preventable

TAVI Beneficial Even in Eldest Patients, Registry Reaffirms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content